Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer

Home > Science Hub > Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer
Back to the list

April 12, 2022

Dirix L et al. Breast Cancer Research and Treatments, 2022

Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer

Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer

Download Publication

You might also be interested by

Webcasts & Webinars

Let's Talk: A Conversation with Dr. Scott Gottlieb

September 10, 2024

More info

CellTalk Blog

Optimal FFPE Tissue Fixation, Processing, and Embedding: A Comprehensive Guide

September 4, 2024

Histopathology

More info

CellTalk Blog

Optimizing your in situ hybridization for success

August 30, 2024

Histopathology

More info

News

Let’s Talk: A Conversation with Former FDA Commissioner Scott Gottlieb

August 14, 2024

More info